|David T. Adams, PharmD, CHIE
Director of U.S. Commercial Specialty Infusion, Shire Pharmaceuticals
David has over 25+ years in the Healthcare and Pharmaceutical Industry. Over his expansive career he has held numerous positions with Eli Lilly, Boehringer Ingelheim, Abbott, AbbVie and Shire focusing on Managed Markets, Market Access, Reimbursement, Marketing, Sales, Business Strategy, Patient Access, as well as Specialty Pharmacy distribution.
During his tenure with Abbott/AbbVie, David and his team developed a strategy to create the first Biopharmaceutical manufacturer owned Specialty Pharmacy, Pharmacy Solutions. The business unit provided HUB services and Specialty Pharmacy programs to support AbbVie’s numerous specialty pharmaceutical products.
In addition to his tenure within the pharmaceutical industry, David also held positions at Highmark BlueCross BlueShield, Chartwell Home Infusion, RX Solutions Infu-sion/Specialty Pharmacy and also owned and operated several retail Pharmacies. David was the Director of Specialty Pipeline Strategy at CVS Health where he was responsible for the specialty pharmacy strategy for pipeline products.
In his current role as the Director of U.S. Commercial Specialty Infusion, with Shire Pharmaceuticals, David is responsible for the strategy and management of Specialty and Infusion Providers for the Shire Rare Disease business unit.
David is a Pharmacist by profession and graduated from the University of Pittsburgh, School of Pharmacy. In 2009 David graduated from the Northwestern University, Kel-logg Graduate School of Business with a focus on Healthcare Executive Management.